Neglected features of lifestyle: Their relevance in non-alcoholic fatty liver disease

Table 1 Differences between non-alcoholic-fatty-liver-disease and control patients

	NAFLD (n = 532)	Controls (n = 667)	P vaule
Age, yr	48.11 ± 9.00	48.60 ± 8.70	0.343
Systolic blood pressure (mmHg)	124.53 ± 9.71	121.21 ± 10.80	< 0.0001
Diastolic blood pressure (mmHg)	78.84 ± 6.72	76.50 ± 6.73	< 0.0001
BMI, kg/m2	30.49 ± 5.55	24.44 ± 3.72	< 0.0001
HOMA	2.89 ± 1.76	1.80 ± 1.28	< 0.0001
eGFR	82.49 ± 14.15	82.15 ± 17.44	0.714
Total cholesterol, mg/dL	205.17 ± 37.16	207.09 ± 38.82	0.387
HDL cholesterol, mg/dL	51.67 ± 15.85	61.45 ± 16.41	< 0.0001
Triglycerides, mg/dL	109.08 ± 42.41	95.23 ± 58.59	< 0.0001
LDL cholesterol, mg/dL	131.98 ± 33.45	126.59 ± 37.29	0.009
γ-GT (U/L)	33.24 ± 29.40	26.03 ± 21.95	< 0.0001
AST (U/L)	20.77 ± 5.91	21.01 ± 7.10	0.530
ALT (U/L)	15.65 ± 4.60	10.40 ± 4.88	< 0.0001
Alkaline phosphatase (U/L)	68.37 ± 18.49	72.75 ± 43.42	0.030
Serum albumin (g/dL)	4.62 ± 0.39	4.53 ± 0.40	< 0.0001
Lifestyle items
AMDS	32.21 ± 0.91	34.91 ± 0.61	< 0.0001
Baecke - physical activity total score	39.82 ± 3.60	41.43 ± 3.32	< 0.0001
Western diet score	22.84 ± 7.87	12.73 ± 2.48	< 0.0001
Sun exposure score	31.43 ± 3.89	35.73 ± 5.25	< 0.0001
Sleep hours	7.86 ± 1.31	7.90 ± 1.23	0.552

BMI: Body mass index; HOMA-IR: Homoeostasis model insulin resistance; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; γ-GT: γ-glutamyl transpeptidase; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; AMDS: Adherence mediterranean diet score; NAFLD: Non-alcoholic-fatty-liver-disease; eGFR: Estimated glomerular filtration rate.